In human cancers, aberrant post-transcriptional modifications, such as alternative splicing and RNA editing, may lead to tumour specific transcriptome diversity. Design By utilising large scale ...

Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach ...

Shares in Wave Life Sciences rose by 74% after it reported clinical data with a pioneering new RNA-editing therapy for alpha-1 antitrypsin deficiency (AATD). Wave claims this is the first clinical ...

AIRNA, a biotech company pioneering RNA editing therapeutics to restore the health of patients with rare and common diseases, ...

Discover the importance of vision, genetic eye disorders, and RNA-based therapies for precision treatment in India and ...

The company’s innovative approach using the Axiomer RNA editing platform to address this genetic driver is promising, with plans to commence clinical testing of their PNPLA3-targeted candidate ...

Taking the success of limited-dosing treatments such as inclisiran further, base-editing RNA therapies aim to provide a permanent, single-course solution for tackling high cholesterol levels.

Discover the top genomics startups revolutionizing genome sequencing technologies to enhance disease prevention and treatment ...

Stanford researchers introduced affordable gene-editing kits ready for the classroom, aiming to make the field more accessible for high school students.

Gaining control of the genetic blueprint of life has been something that comic book and science fiction writers have dreamed ...

CAMBRIDGE, Mass. - Wave Life Sciences Ltd . (NASDAQ:WVE), a clinical-stage biotechnology company with a market capitalization of $1.87 billion, has announced the commencement of its Phase 1 INLIGHT ...